Aemetis (NASDAQ:AMTX) Earns Buy Rating from HC Wainwright

HC Wainwright reissued their buy rating on shares of Aemetis (NASDAQ:AMTX - Free Report) in a research note published on Monday,Benzinga reports. The brokerage currently has a $28.00 price objective on the specialty chemicals company's stock.

Separately, Ascendiant Capital Markets cut their price objective on shares of Aemetis from $20.00 to $19.00 and set a "buy" rating for the company in a report on Tuesday, September 3rd. One research analyst has rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, Aemetis presently has an average rating of "Moderate Buy" and an average target price of $12.95.

Aemetis Price Performance

Shares of NASDAQ AMTX traded down $0.03 during trading on Monday, reaching $2.59. 644,613 shares of the stock traded hands, compared to its average volume of 795,477. The stock has a market capitalization of $128.81 million, a P/E ratio of -1.15 and a beta of 1.35. Aemetis has a 52-week low of $2.10 and a 52-week high of $7.03. The company has a 50-day moving average of $3.30 and a 200-day moving average of $3.00.

Aemetis (NASDAQ:AMTX - Get Free Report) last released its quarterly earnings data on Tuesday, November 12th. The specialty chemicals company reported ($0.38) EPS for the quarter, beating the consensus estimate of ($0.47) by $0.09. The business had revenue of $81.44 million for the quarter, compared to analysts' expectations of $77.79 million. During the same period last year, the company earned ($0.59) earnings per share. Analysts expect that Aemetis will post -2.02 earnings per share for the current fiscal year.

Institutional Trading of Aemetis

A number of hedge funds and other institutional investors have recently bought and sold shares of AMTX. Rhumbline Advisers raised its holdings in shares of Aemetis by 2,837.1% in the 2nd quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company's stock valued at $157,000 after acquiring an additional 50,528 shares in the last quarter. Susquehanna Fundamental Investments LLC raised its stake in Aemetis by 287.4% in the second quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company's stock valued at $379,000 after purchasing an additional 93,536 shares in the last quarter. Bank of New York Mellon Corp purchased a new stake in Aemetis in the second quarter valued at approximately $306,000. Wellington Management Group LLP bought a new stake in Aemetis during the third quarter valued at approximately $177,000. Finally, Hutchinson Capital Management CA purchased a new position in Aemetis in the 2nd quarter worth approximately $70,000. Institutional investors own 27.02% of the company's stock.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.